Vaccine News and Research

Latest Vaccine News and Research

New bivalent vaccine shows promising results against key fish pathogens

The efficacy of a bivalent vaccine against Aeromonas hydrophila (A. hydrophila) and Streptococcus agalactiae (S. agalactiae).

30 Oct 2023

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

Redefining the battle against Alzheimer's with tau-focused treatments

Researchers explore the potential of tau-targeting therapies in treating Alzheimer's disease, focusing on immunotherapies and strategies to improve their efficacy. The study dives into the complex biology of tau proteins, their modifications, and how they can be targeted to halt the progression of Alzheimer's.

29 Oct 2023

Broad spread and upsurge cholera outbreak in Africa

Announcing a new article publication for Zoonoses journal. A multi-country cholera outbreak has occurred in several developing countries in Africa, Asia and Oceania since mid-2021.

27 Oct 2023

A new era of vaccines leaves old questions about prices unanswered

The world is entering a new era of vaccines. Following the success of covid-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus's structure, putting a host of new vaccines on the horizon.

27 Oct 2023

Malaria protein discovery opens new avenues for combating deadly infection

The discovery of a malaria protein that helps the parasite grow inside red blood cells and plays a key regulatory role in the parasite's immune evasion tactics could pave the way for new vaccines or therapeutics to combat the deadly infection.

26 Oct 2023

Study helps identify children at the highest risk of severe RSV infection

A new study helps to identify children who are at the highest risk of a severe respiratory syncytial virus (RSV) infection and who would thus benefit most from new RSV prevention measures.

26 Oct 2023

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

The study found that both children and care providers in U.S. child-care centers showed low rates of COVID-19 transmission, challenging the notion that these settings are high-risk environments for the virus. The results could have implications for revising guidelines on school and child-care center closures.

25 Oct 2023

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

Zika virus infection in pregnant rhesus macaques slows fetal growth and affects how infants and mothers interact in the first month of life, according to a new study from researchers at the California National Primate Research Center at the University of California, Davis.

25 Oct 2023

Oxford Vaccine Group launches a pioneering study into human immunity

This study will test the responses of cells in lymph nodes before and after immunization with flu and COVID-19 vaccines and compare reactions in older and younger adults.

25 Oct 2023

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

The effects of vaccine booster doses on the adaptive evolution of the virus.

25 Oct 2023

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the "entire history of Bangladesh," said environmental historian Iftekhar Iqbal

24 Oct 2023

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Study investigates the receptor affinity and antigenicity of the SARS-CoV-2 Omicron BA.2.86 variant, revealing that it does not show higher resistance to neutralization by human sera than other recent variants. Despite its high number of mutations and receptor affinity, the variant is slightly more sensitive to neutralization than the EG.5.1 variant, warranting continued surveillance.

24 Oct 2023

Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice

Previous
1
...
76
77
78
79
80
81
82
...
1151
Next

Vaccine News and Research

Latest Vaccine News and Research

New bivalent vaccine shows promising results against key fish pathogens

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Redefining the battle against Alzheimer's with tau-focused treatments

Broad spread and upsurge cholera outbreak in Africa

A new era of vaccines leaves old questions about prices unanswered

Malaria protein discovery opens new avenues for combating deadly infection

Study helps identify children at the highest risk of severe RSV infection

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

Oxford Vaccine Group launches a pioneering study into human immunity

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Epidemic: What good is a vaccine when there is no rice?

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice

New consortium to build on breakthroughs in malaria research to develop P. vivax vaccines

Research suggests shorter isolation periods for children with COVID-19

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

eBook: Advancing infectious disease vaccine development eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in